SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010084
Filing Date
2019-11-06
Accepted
2019-11-06 09:06:31
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20190930x10q.htm 10-Q 1555967
2 EX-10.1 albo-20190930ex1016c4657.htm EX-10.1 150925
3 EX-31.1 albo-20190930ex3111c2ddb.htm EX-31.1 11740
4 EX-31.2 albo-20190930ex312883246.htm EX-31.2 12424
5 EX-32.1 albo-20190930ex32134d69f.htm EX-32.1 12229
6 GRAPHIC albo20190930ex1016c4657001.jpg GRAPHIC 15198
  Complete submission text file 0001558370-19-010084.txt   3994645

Data Files

Seq Description Document Type Size
7 EX-101.INS albo-20190930.xml EX-101.INS 519120
8 EX-101.SCH albo-20190930.xsd EX-101.SCH 28684
9 EX-101.CAL albo-20190930_cal.xml EX-101.CAL 38306
10 EX-101.DEF albo-20190930_def.xml EX-101.DEF 74649
11 EX-101.LAB albo-20190930_lab.xml EX-101.LAB 269709
12 EX-101.PRE albo-20190930_pre.xml EX-101.PRE 181384
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 191195253
SIC: 2834 Pharmaceutical Preparations